RHOPRESSA Trademark

Trademark Overview

On Tuesday, March 25, 2014, a trademark application was filed for RHOPRESSA with the United States Patent and Trademark Office. The USPTO has given the RHOPRESSA trademark a serial number of 86231355. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, May 30, 2023. This trademark is owned by Aerie Pharmaceuticals, Inc.. The RHOPRESSA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of glaucoma and ocular hypertension
rhopressa

General Information

Serial Number86231355
Word MarkRHOPRESSA
Filing DateTuesday, March 25, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, May 30, 2023
Registration Number5317370
Registration DateTuesday, October 24, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 19, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of glaucoma and ocular hypertension
Translation of Words in MarkThe wording "RHOPRESSA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 7, 2014
Primary Code005
First Use Anywhere DateFriday, September 1, 2017
First Use In Commerce DateFriday, September 1, 2017

Trademark Owner History

Party NameALCON INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressFribourg CH-1701
CH
Party NameAerie Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBedminister, NJ 07921
Party NameAerie Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBedminister, NJ 07921
Party NameAerie Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBedminister, NJ 07921

Trademark Events

Event DateEvent Description
Tuesday, February 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 13, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 13, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 1, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 1, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 30, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, May 30, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, May 30, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, March 22, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, November 17, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, October 24, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 29, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 29, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 29, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 24, 2017REGISTERED-PRINCIPAL REGISTER
Saturday, September 16, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, September 15, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, September 11, 2017STATEMENT OF USE PROCESSING COMPLETE
Tuesday, September 5, 2017USE AMENDMENT FILED
Tuesday, September 5, 2017TEAS STATEMENT OF USE RECEIVED
Friday, April 28, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 27, 2017SOU EXTENSION 5 GRANTED
Wednesday, March 29, 2017SOU EXTENSION 5 FILED
Wednesday, March 29, 2017SOU TEAS EXTENSION RECEIVED
Friday, September 23, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 22, 2016SOU EXTENSION 4 GRANTED
Monday, September 12, 2016SOU EXTENSION 4 FILED
Monday, September 12, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, April 26, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 25, 2016SOU EXTENSION 3 GRANTED
Monday, March 21, 2016SOU EXTENSION 3 FILED
Friday, April 22, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 21, 2016SOU TEAS EXTENSION RECEIVED
Friday, August 7, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 6, 2015SOU EXTENSION 2 GRANTED
Tuesday, August 4, 2015SOU EXTENSION 2 FILED
Tuesday, August 4, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, May 5, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, May 2, 2015SOU EXTENSION 1 GRANTED
Wednesday, March 25, 2015SOU EXTENSION 1 FILED
Saturday, May 2, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 25, 2015SOU TEAS EXTENSION RECEIVED
Wednesday, March 25, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 14, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 19, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 19, 2014PUBLISHED FOR OPPOSITION
Wednesday, July 30, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 17, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 15, 2014ASSIGNED TO LIE
Friday, June 27, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 26, 2014EXAMINER'S AMENDMENT ENTERED
Thursday, June 26, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 26, 2014EXAMINERS AMENDMENT E-MAILED
Thursday, June 26, 2014EXAMINERS AMENDMENT -WRITTEN
Thursday, June 26, 2014ASSIGNED TO EXAMINER
Monday, April 7, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 28, 2014NEW APPLICATION ENTERED

Related Keywords

rhopressa ocular hypertension glaucoma treatment preparations pharmaceutical